PHARMING GROUP (NL0010391025) — research page
NL · nl-cm-kg/XAMS/NL0010391025 · as of 2026-11-11
Identity and listing
The issuer is PHARMING GROUP, listed on Euronext Amsterdam under ticker NL0010391025, with ISIN NL0010391025 and LEI 724500DCJ9MPG74JEH91. Its security type is Corporate and its jurisdiction is Netherlands (KVK-registered). Its segment is not on the record, and its sector is not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | PHARMING GROUP | source · 2026-11-11 |
| exchange | Euronext Amsterdam | source · 2026-11-11 |
| ticker | NL0010391025 | source · 2026-11-11 |
| ISIN | NL0010391025 | source · 2026-11-11 |
| LEI | 724500DCJ9MPG74JEH91 | source · 2026-11-12 |
| security type | Corporate | source · 2026-11-11 |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | Netherlands (KVK-registered) | source · 2026-11-11 |
| status | listed, not halted | source · 2026-11-12 |
The disclosure read
The record holds 54 filings in the window 2025-11-11 to 2026-11-11, falling on 26 filing days. The filings are 15 ad hoc, 4 AGM/EGM, 8 directors' dealings, 15 newswire releases and 12 results. The median gap between filing days is 8 days. The latest filing is a newswire release dated 2026-11-06, 5 days before the record date of 2026-11-11. On Euronext Amsterdam the record holds 123 issuers with a median cadence gap of 10.2 days, a median of 15 filings and a median latency of 7.0 days. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 54 | 8 | 5 |
| exchange median: Euronext Amsterdam (123 issuers) | 15 | 10.2 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | newswire_release | MHRA approves Pharming’s Joenja® (leniolisib) as first | |
| 2026-11-06 | agm_egm | inside information | Azerion publishes the Notice of its Extraordinary General Meeting of 18 December 2026 regarding the appointment of new members to the Management and Supervisory Boards |
| 2026-10-27 | results | Pharming Group reports third quarter 2026 financial | |
| 2026-10-27 | results | Pharming Group reports third quarter 2026 financial results | |
| 2026-10-27 | results | inside information | Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November |
window 2025-11-11 to 2026-11-11 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor is not on the record. The record carries the annual report link only, as a source link and not a read. Auditor changes are not on the record.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag shows listed, not halted.
Orderability
The outcome is not determinable under rule version acm-68000/nl/mifid-ii-product-governance/r1, with chapter as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.
rule acm-68000/nl/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 8 research houses: Oppenheimer & Co. Inc., Portzamparc / BNP Paribas, Canaccord Genuity, First Berlin Research, H.C. Wainwright, Jefferies, Van Lanschot Kempen and RBC Capital Markets.
| research house | analyst | source · read date |
|---|---|---|
| Oppenheimer & Co. Inc. | Joseph Pantginis | issuer page · 2026-11-12 |
| Portzamparc / BNP Paribas | Mohamed Kaabouni | issuer page · 2026-11-12 |
| Canaccord Genuity | Whitney Ijem | issuer page · 2026-11-12 |
| First Berlin Research | Simon Scholes | issuer page · 2026-11-12 |
| H.C. Wainwright | Joseph Pantginis | issuer page · 2026-11-12 |
| Jefferies | Benjamin Jackson | issuer page · 2026-11-12 |
| Van Lanschot Kempen | Sushila Hernandez | issuer page · 2026-11-12 |
| RBC Capital Markets | Harry Sephton | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (identity.exchange)
- 10.2
- https://api.gleif.org/api/v1/lei-records/724500DCJ9MPG74JEH91 (identity.jurisdiction)
- 10.3
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.4
- https://mcp.nl-cm-kg.ai/events/XAMS/NL0010391025 (the disclosure lines)
- 10.5
- https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current (the halt flag)
- 10.6
- https://mcp.nl-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://www.pharming.com/investors/analyst-coverage (coverage)
- 10.8
- https://mcp.nl-cm-kg.ai/record/XAMS/NL0010391025 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"NL0010391025"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:9c5e5c140d6ba02b.